Actualizar mis citas con la selección
Presentar
resultados
Fan-Ngai-Hung I, Lung K-C, Tso EY-K, Liu R, Chung TW-H, Chu M-Y, et al..
Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial.
Lancet 2020;395:30 de mayo. [Ref.ID 103649]
Haight BR, Learned SM, Lafont CM, Fudala PJ, Zhao Y, Garofalo AS, Greenwald MK, Nadipelli VR, Linq W, Heidbreder C, RB-US-13-0001 Study Investigators.
Efficacy and safety of a monthly buprenorphine depot injection for opioid use disorder: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet 2019;393:23 de febrero. [Ref.ID 103111]
Riva N, Mora G, Sorarù G, Lunetta C, Ferraro OE, Falzone Y, Leocani L, Fazio R, Comola M, Comi G, CANALS Study Group.
Safety and efficacy of nabiximols on spasticity symptoms in patients with motor neuron disease (CANALS): a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial.
Lancet Neurol 2018;18:febrero. [Ref.ID 102909]
Actualizar mis citas con la selección